MEGHAN KENNEDY: Open Payments
NPI 1821238569 · VALLEJO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,228 in 80 payments from 11 companies in 2025. Trend: 2023 $1,275 · 2024 $2,485 · 2025 $2,228
Food & beverage: $2,044Education: $183
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 14 | $438 |
| Janssen Biotech, Inc. | 10 | $360 |
| ABBVIE INC. | 12 | $323 |
| Arcutis Biotherapeutics, Inc. | 4 | $193 |
| Regeneron Healthcare Solutions, Inc. | 8 | $186 |
| Novartis Pharmaceuticals Corporation | 8 | $185 |
| Lilly USA, LLC | 8 | $164 |
| Galderma Laboratories, L.P. | 6 | $124 |
| GENZYME CORPORATION | 4 | $121 |
| Incyte Corporation | 5 | $110 |
Products named: Bimzelx, TREMFYA, DUPIXENT, Zoryve, SKYRIZI, TALTZ, COSENTYX, NEMLUVIO.
Industry payments across CA — which companies pay providers there.
